These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33120049)

  • 21. Ghrelin alleviates placental dysfunction by down-regulating NF-κB phosphorylation in LPS-induced rat model of preeclampsia.
    Shen J; Hu N; Wang Z; Yang L; Chen R; Zhang L; Wang X
    Eur J Pharmacol; 2024 Jun; 972():176569. PubMed ID: 38593930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of LAMA4 Gene in Regulating Extravillous Trophoblasts in Pathogenesis of Preeclampsia.
    Ji Y; Zhou L; Wang G; Qiao Y; Tian Y; Feng Y
    Med Sci Monit; 2019 Dec; 25():9630-9636. PubMed ID: 31842202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin enhances trophoblast invasion and represses soluble fms-like tyrosine kinase 1 production: a putative mechanism for preventing preeclampsia.
    Su MT; Wang CY; Tsai PY; Chen TY; Tsai HL; Kuo PL
    J Hypertens; 2019 Dec; 37(12):2461-2469. PubMed ID: 31335509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular hydrogen ameliorates several characteristics of preeclampsia in the Reduced Uterine Perfusion Pressure (RUPP) rat model.
    Ushida T; Kotani T; Tsuda H; Imai K; Nakano T; Hirako S; Ito Y; Li H; Mano Y; Wang J; Miki R; Yamamoto E; Iwase A; Bando YK; Hirayama M; Ohno K; Toyokuni S; Kikkawa F
    Free Radic Biol Med; 2016 Dec; 101():524-533. PubMed ID: 27789293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia.
    Nagamatsu T; Fujii T; Kusumi M; Zou L; Yamashita T; Osuga Y; Momoeda M; Kozuma S; Taketani Y
    Endocrinology; 2004 Nov; 145(11):4838-45. PubMed ID: 15284201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IFI16 mediates soluble Flt-1 and endoglin production by trophoblast cells.
    Li N; Fu Y; Chen W; Hu GQ; Zhou M; Yu SX; Zhang XJ; Du CT; Yang YJ
    J Hypertens; 2015 Aug; 33(8):1658-65. PubMed ID: 26002845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial Dysfunction.
    Onda K; Tong S; Beard S; Binder N; Muto M; Senadheera SN; Parry L; Dilworth M; Renshall L; Brownfoot F; Hastie R; Tuohey L; Palmer K; Hirano T; Ikawa M; Kaitu'u-Lino T; Hannan NJ
    Hypertension; 2017 Mar; 69(3):457-468. PubMed ID: 28115513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy.
    Zhou CC; Ahmad S; Mi T; Xia L; Abbasi S; Hewett PW; Sun C; Ahmed A; Kellems RE; Xia Y
    Circ Res; 2007 Jan; 100(1):88-95. PubMed ID: 17158338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIF-2α, but not HIF-1α, mediates hypoxia-induced up-regulation of Flt-1 gene expression in placental trophoblasts.
    Sasagawa T; Nagamatsu T; Morita K; Mimura N; Iriyama T; Fujii T; Shibuya M
    Sci Rep; 2018 Nov; 8(1):17375. PubMed ID: 30478339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
    Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procyanidin B2 ameliorates endothelial dysfunction and impaired angiogenesis via the Nrf2/PPARγ/sFlt-1 axis in preeclampsia.
    Liu L; Wang R; Xu R; Chu Y; Gu W
    Pharmacol Res; 2022 Mar; 177():106127. PubMed ID: 35150862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resveratrol inhibits the release of soluble fms-like tyrosine kinase (sFlt-1) from human placenta.
    Cudmore MJ; Ramma W; Cai M; Fujisawa T; Ahmad S; Al-Ani B; Ahmed A
    Am J Obstet Gynecol; 2012 Mar; 206(3):253.e10-5. PubMed ID: 22197494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-α.
    Murphy SR; LaMarca BB; Parrish M; Cockrell K; Granger JP
    Am J Physiol Regul Integr Comp Physiol; 2013 Jan; 304(2):R130-5. PubMed ID: 23193111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Jumonji Domain Containing Protein 6 Is Decreased in Human Preeclamptic Placentas and Regulates sFLT-1 Splice Variant Production.
    Palmer KR; Tong S; Tuohey L; Cannon P; Ye L; Hannan NJ; Brownfoot FC; Illanes SE; Kaitu'u-Lino TJ
    Biol Reprod; 2016 Mar; 94(3):59. PubMed ID: 26819475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombin regulates soluble fms-like tyrosine kinase-1 (sFlt-1) expression in first trimester decidua: implications for preeclampsia.
    Lockwood CJ; Toti P; Arcuri F; Norwitz E; Funai EF; Huang ST; Buchwalder LF; Krikun G; Schatz F
    Am J Pathol; 2007 Apr; 170(4):1398-405. PubMed ID: 17392178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Placental trophoblast-specific overexpression of chemerin induces preeclampsia-like symptoms.
    Tan L; Chen Z; Sun F; Zhou Z; Zhang B; Wang B; Chen J; Li M; Xiao T; Neuman RI; Niu J; Verdonk K; Lu X; Zhang JV; Danser AHJ; Yang Q; Fan X
    Clin Sci (Lond); 2022 Feb; 136(4):257-272. PubMed ID: 35103285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction.
    Brownfoot FC; Hannan NJ; Cannon P; Nguyen V; Hastie R; Parry LJ; Senadheera S; Tuohey L; Tong S; Kaitu'u-Lino TJ
    EBioMedicine; 2019 Mar; 41():636-648. PubMed ID: 30824385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EGFR (Epidermal Growth Factor Receptor) Signaling and the Mitochondria Regulate sFlt-1 (Soluble FMS-Like Tyrosine Kinase-1) Secretion.
    Hastie R; Brownfoot FC; Pritchard N; Hannan NJ; Cannon P; Nguyen V; Palmer K; Beard S; Tong S; Kaitu'u-Lino TJ
    Hypertension; 2019 Mar; 73(3):659-670. PubMed ID: 30636550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta.
    Jena MK; Sharma NR; Petitt M; Maulik D; Nayak NR
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32599856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.